MASS vs TXG
908 Devices Inc. - Common Stock · 10x Genomics, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | MASS | TXG |
|---|---|---|
| Price | $11.25 | $70.11 |
| Market Cap | $465.00M | $8.95B |
| P/E | 23.86 | — |
| P/B | 3.67 | 10.84 |
| P/S | 8.27 | 13.93 |
| ROE | 15.4% | -5.3% |
| Net Margin | 34.7% | -6.8% |
| Gross Margin | 50.6% | 69.1% |
| Revenue Growth | 17.7% | 5.2% |
| Dividend Yield | — | — |
| EPS | $0.47 | -$0.34 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.